Free shipping on all orders over $ 500

PD 144418 oxalate 

Cat. No. M28864

All AbMole products are for research use only, cannot be used for human consumption.

PD 144418 oxalate  Structure

Price and Availability

For this product's availability, delivery time and price, please email [email protected] directly or click the "Inquiry Now" button below.


Quality Control & Documentation
Biological Activity

PD 144418 oxalate is a highly affinity, potent and selective sigma 1 (σ1) receptor ligand (Ki values of 0.08 nM and 1377 nM for σ1 and σ2 respectively). PD 144418 oxalate devoids of any significant affinity for other receptors, ion channels and enzymes. PD 144418 oxalate shows potential antipsychotic activity.

Chemical Information
Molecular Weight 372.41
Formula C20H24N2O5
CAS Number 1794760-28-3
Form Solid
Storage 4°C, dry, sealed
Related Sigma Receptor Products
IPAG 

IPAG is a potent sigma-1 receptor antagonist with a pKi of 4.3.

PB28 dihydrochloride 

PB28 dihydrochloride, a cyclohexylpiperazine derivative, is a high affinity and selective sigma 2 (σ2) receptor agonist with a Ki of 0.68 nM.

(±)-PPCC hemioxalate 

(±)-PPCC hemioxalate is a compound that has the ability to regulate the activity of the sigma-1 receptor.

(+)-Igmesine hydrochloride

(+)-Igmesine hydrochloride (JO1784) is an orally active and selective σ receptor ligand with neuroprotective and anti-amnesic activities.

ANAVEX 3-71

ANAVEX 3-71 is an orally active SIGMAR1 receptor agonist and M1-positive variant modulator for studies related to schizophrenia.

  Catalog
Abmole Inhibitor Catalog




Keywords: PD 144418 oxalate  supplier, Sigma Receptor, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.